AAAAAA
Results:
1-12
|
Results: 12
Comparison between genotype and phenotype identifies a high-risk population carrying BRCAI mutations
Authors:
Cortesi, L
Turchetti, D
Bertoni, C
Bellei, R
Mangone, L
Vinceti, M
Federico, M
Silingardi, V
Ferrari, S
Citation: L. Cortesi et al., Comparison between genotype and phenotype identifies a high-risk population carrying BRCAI mutations, GENE CHROM, 27(2), 2000, pp. 130-135
Authors:
Turchetti, D
Cortesi, L
Federico, M
Bertoni, C
Mangone, L
Ferrari, S
Silingardi, V
Citation: D. Turchetti et al., BRCA1 mutations and clinicopathological features in a sample of Italian women with early-onset breast cancer, EUR J CANC, 36(16), 2000, pp. 2083-2089
Authors:
Pescatori, ES
Silingardi, V
Galeazzi, GM
Rigatelli, M
Ranzi, A
Artibani, W
Citation: Es. Pescatori et al., Audiovisual sexual stimulation by virtual glasses is effective in inducingcomplete cavernosal smooth muscle relaxation: a pharmacocavernosometric study, INT J IMPOT, 12(2), 2000, pp. 83-88
Authors:
Cascinu, S
Bichisao, E
Amadori, D
Silingardi, V
Giordani, P
Sansoni, E
Luppi, G
Catalano, V
Agostinelli, R
Catalano, G
Citation: S. Cascinu et al., High-dose loperamide in the treatment of 5-fluorouracil-induced diarrhea in colorectal cancer patients, SUPP CARE C, 8(1), 2000, pp. 65-67
Authors:
Sabbatini, R
Federico, M
Morselli, M
Depenni, R
Cagossi, K
Luppi, M
Torelli, G
Silingardi, V
Citation: R. Sabbatini et al., Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy, J CL ONCOL, 18(9), 2000, pp. 1914-1920
Authors:
Federico, M
Sabbatini, R
Morselli, M
Depenni, R
Cagossi, K
Luppi, M
Torelli, G
Silingardi, V
Citation: M. Federico et al., Detection of circulating tumor by reverse transcriptase polymerase chain reaction, J CL ONCOL, 18(17), 2000, pp. 3196-3197
Authors:
Gobbi, PG
Ghirardelli, ML
Avanzini, P
Baldini, L
Quarta, G
Stelitano, C
Broglia, C
Loni, C
Silingardi, V
Ascari, E
Citation: Pg. Gobbi et al., A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian Lymphoma Study Group (GISL), HAEMATOLOG, 85(3), 2000, pp. 263-268
Authors:
Stelitano, C
Baldini, L
Pieresca, C
Callea, V
Angrilli, F
Clo, V
Partesotti, G
Merli, F
Cavanna, L
Morabito, F
Federico, M
Brugiatelli, M
Silingardi, V
Citation: C. Stelitano et al., Validation of the International Prognostic Index in Working Formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry, HAEMATOLOG, 85(2), 2000, pp. 154-159
Authors:
Fomarini, B
D'Ambrosio, C
Natoli, C
Tinari, N
Silingardi, V
Iacobelli, S
Citation: B. Fomarini et al., Adhesion to 90K (Mac-2 BP) as a mechanism for lymphoma drug resistance in vivo, BLOOD, 96(9), 2000, pp. 3282-3285
Authors:
Longo, G
Fiorani, C
Sacchi, S
Callea, V
Lombardo, M
Federico, M
Stelitano, C
Angrilli, F
Vallisa, D
Gobbi, PG
Ilariucci, F
Frassoldati, A
Petrini, M
Silingardi, V
Citation: G. Longo et al., Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma, HAEMATOLOG, 84(5), 1999, pp. 425-430
Authors:
Federico, M
Maiorana, A
Mangone, L
Turchetti, D
Canossi, B
Cortesi, L
Romagnoli, R
Silingardi, V
Citation: M. Federico et al., Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal, BREAST CANC, 55(3), 1999, pp. 213-221
Authors:
Callea, V
Clo, V
Morabito, F
Baldini, L
Stelitano, C
Narni, F
Avanzini, P
Brugiatelli, M
Silingardi, V
Citation: V. Callea et al., Retrospective analysis of mantle cell lymphoma: experience of the "Gruppo Italiano per lo Studio dei Linfomi" (GISL), HAEMATOLOG, 83(11), 1998, pp. 993-997
Risultati:
1-12
|